Clinical-stage company developing next-generation neuromodulation technology capable of treating depression without pharmaceutical therapies and related side effects.
Magnus Medical
Neurology
Total Addressable Market
$2 billion+
Red Tree Board Member(s)
Red Tree Board Member
Heath Lukatch, Ph.D.
Red Tree Board Observer
Krishna Polu, M.D.
Red Tree Participation
Co-led Series A
